Quimbaya Gold Inc. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025May 30, 2025 8:00 AM EDT | Source: VID MediaVancouver, British Columbia--(Newsfile Corp. - May 30, 2025) - Quimbaya Gold Inc. (CSE: QIM) (OTCQB: QIMGF) (FSE: K05), The Next Big Gold Discovery in Columbia, is pleased to announce that it will be participating in THE Mining Investment Event, Canada’s Only Tier 1 Global Mining Investment Conference©, taking place June 3-5, 2025, at the Quebec Conv ...

SINGAPORE, May 30, 2025 /PRNewswire/ -- Mega Matrix Inc. ("MPU" or the "Company") (NYSE American: MPU), today announced that the Company's Board of Directors approved the purchase of Bitcoin and/or Ethereum to hold as a treasury reserve asset.Yucheng Hu, Chief Executive Officer of MPU, commented, "Bitcoin and Ethereum represent next-generation treasury assets that enhance our financial strategy. While remaining focused on our core short drama streaming business, we believe this move strengthens our long-ter ...

DENVER, May 30, 2025 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen” or the “Company”), the nation’s largest specialty hydroponic and organic gardening retailer, today announced that management will participate in Oppenheimer’s 25th Annual Consumer Growth and E-Commerce Conference, to be held virtually on June 9–11, 2025. Darren Lampert, GrowGen’s Chief Executive Officer and Co-Founder, will participate in a Fireside Chat on Monday, June 9, 2025 at 9:00 a.m. Eastern Time. A webcast of the ...

Key abstract presentations showcase significant advancements in clinical care, artificial intelligence, and fluid management, demonstrating Fresenius Medical Care's commitment to improving patient outcomes. Top Abstract recognition for "Prevalence and Patterns of Intradialytic Arterial Oxygen Saturation Instability: Observations in a Large U.S. Hemodialysis Cohort," presented in the "Dialysis" category. CONVINCE trial analysis links hemodiafiltration to slower health decline and better quality of life in k ...

Singapore, Singapore--(Newsfile Corp. - May 30, 2025) - FingerMotion, Inc. (NASDAQ: FNGR) (the "Company" or "FingerMotion"), a mobile services, data, and technology company, is pleased to report its financial results for the fiscal year ended February 28, 2025. To review the full financial results, please view the Company's recent 10-K filing at www.sec.gov/edgar/search, which should be read in connection with this news release.FY 2025 Financial Summary (results expressed in US$ unless otherwise indicated) ...

HOUSTON, May 30, 2025 /PRNewswire/ -- EOG Resources, Inc. (EOG) today announced a definitive agreement with Canada Pension Plan Investment Board (CPP) and Encino Energy under which EOG will acquire Encino Acquisition Partners (EAP or Encino) for $5.6 billion, inclusive of EAP's net debt. EOG currently expects to fund the acquisition through $3.5 billion of debt and $2.1 billion of cash on hand."This acquisition combines large, premier acreage positions in the Utica, creating a third foundational play for EO ...

Core Insights - Apple (NASDAQ: AAPL) is currently facing challenges, with shares trading around $200, which is approximately 20% below its all-time highs reached in December [1] Company Overview - Historically, Apple has delivered a solid annual return of 26% since the introduction of the iPhone in 2007 [1] - The company is experiencing a period of struggle, indicating potential concerns regarding its market performance and investor sentiment [1] Analyst Background - Daniel Martins, the founder of DM Martins Research, emphasizes building efficient and replicable portfolios that balance growth with reduced downside risk [1] - Martins has extensive experience in equity research and investment management, having worked with notable firms such as FBR Capital Markets and Bridgewater Associates [1] - His research has been featured in major publications, indicating a strong reputation in the investment community [1]

Core Points - AbbVie has launched a multi-year partnership with the Chicago Cubs to support cancer advocacy through the "Striking Out Cancer" campaign, which begins with the Cubs' game against the Cincinnati Reds [1][3] - For every strikeout by a Cubs pitcher at home during the 2025 regular season, AbbVie will donate $233, reflecting the statistic of approximately 233 Americans diagnosed with cancer every hour [1][2] - The funds raised will be donated to Cubs Charities, benefiting non-profit organizations like Conquer Cancer®, which focuses on advancing cancer research and patient care [1][3][7] Company Overview - AbbVie is a global biopharmaceutical company dedicated to discovering and delivering transformative medicines across various therapeutic areas, including oncology [2][4] - The company aims to address serious health issues and improve patient outcomes through innovative therapies for cancers such as leukemias, lymphomas, and lung cancer [2][4] Partner Overview - The Chicago Cubs, a historic Major League Baseball franchise, have a commitment to community engagement and charitable initiatives, including the "Striking Out Cancer" campaign [5][6] - Cubs Charities has invested over $51 million in community programs since 2009, focusing on youth development and safe play environments [6] Beneficiary Overview - Conquer Cancer®, the ASCO Foundation, has awarded over $203 million in grants to improve cancer care and research since its inception in 1984 [7]

I wrote about Kanzhun Limited (NASDAQ: BZ ) previously with a reiteration of my buy rating, as the 4Q24 results boosted my confidence in the growth outlook. I reiterate my buy rating for BZ, as the 1Q25 results strengthenI am an individual investor that is now fully focus on managing my own capital that I have saved up over the years. My investing background spreads across a wide spectrum as I believe there are merits to each approach, for instance: Fundamental investing [Bottoms-up etc.], Technical investi ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...